(Date:12/2/2009)...e/ -- Reportlinker.com announces that a new market..., Neurostimulation - A Global Market Perspectiv...rostimulation---A-Global-Market-Perspective.html ...thused by the growing base of aging population, an...as, Parkinson,s, and Alzheimer,s disease. Widespre...
(Date:12/2/2009)...wire-FirstCall/ -- Peregrine Pharmaceuticals, Inc....ient enrollment in a dose confirmation and dosimet... glioblastoma multiforme (GBM), the deadliest form... antibody linked to a radioisotope being developed...cifically targets cells at the center of brain tum...
(Date:12/2/2009)...ember 2 Gamida Cell announced toda...animal study) safety and,efficacy of a gene therap...nell Medical College and Gamida Cell. The product ... as Cooley,s Anemia. , Gamida Cell is dev...o,populations of stem/progenitor cells. The compa...
(Date:12/2/2009)...re-Asia/ -- The world is going through,extraordina...s part of many,businesses and industries. It turns...immune to the economic downturn, because illness d...t of the difficult times this year, the pharmaceut...amp;D center in Shanghai, the largest of,its kind ...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3..., EDMONTON, Aug. 1 /PRNewswire-FirstCall/ - BioMS...he treatment of multiple sclerosis (MS), today,ann...n its phase III,clinical trial of MBP8298 (dirucot... (SPMS). The trial, named MAESTRO-03, includes app... 68 trial sites in the U.S., "We have had great s...
...1 /Xinhua-PRNewswire-FirstCall/ --,China Pharma Ho... CPHI),which develops, manufactures, and markets l...ts in China, today announced the Company will host...ednesday, August 6, 2008 to,discuss these results....rlier that same day., Ms. Zhilin Li, President an...
... Aug. 1 Sanofi,Pasteur, the vaccines division of ...cine (Fluzone(R), Influenza Virus Vaccine) in the ...1.3 million doses of influenza,vaccine began shipp...,2008-2009 formulation by the U.S. Food and Drug A...ipments to health-care providers and to the Center...
Other Biology Technology:BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 2BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 3BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 4China Pharma Holdings, Inc. to Host Second Quarter 2008 Earnings Conference Call at 10 a.m. EDT Wednesday August 6, 2008 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season 5...A or Isolated Sequence) siRNA Test System is desig...ion of a potential of any DNA sequence to serve as...Current computer-based RNAi target searching algor...selected sequence to be a good target from 30% to ...
...tabilizer is a is a bovine protein-free alternativ...an aqueous solution that contains non-toxic chemic...H 6.6 - 7.2. This product contains a combination ...ioxane as a preservative. StabilGuard Choice Stab...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Novus Biologicals
...ated for mounting tissue specimens, cell smears, a...stochemical methods for viewing by light microscop...C, that are alcohol-soluble or incompatible with o...lides are cover-slipped forming a coating that fac...
Biology Products: